Drs. Navin C. Shah and Vladimir Ioffe share their insight on the Urology Times September 2020 Cover Story, “PSA Screening in Prostate Cancer—The Controversy Continues.”
Drs. Navin C. Shah and Vladimir Ioffe share their insight on the Urology Times September 2020 Cover Story, “PSA Screening in Prostate Cancer—The Controversy Continues.”
Maternal postpartum depression (PPD) is a widely studied and discussed phenomenon, whereas much less is known about the concept of paternal PPD. Nonetheless, recent studies have indicated that depression in new fathers is a significant public health concern.
Maternal postpartum depression (PPD) is a widely studied and discussed phenomenon, whereas much less is known about the concept of paternal PPD. Nonetheless, recent studies have indicated that depression in new fathers is a significant public health concern.
The following letter was sent to Urology Times in response to a previously published letter to the editor, "Dear USPSTF: Don't discount value of PSA in men 70+."
This article provides an overview of the new 2018 ICD-10-CM codes, revisions, and deletions that are relevant to urology practice.
It’s been a busy couple of months for health policy on Capitol Hill, as the AACU and UROPAC continue to make headway in their efforts to strengthen urology’s voice in Washington.
"Overall, the take-home message is that [blue light cystoscopy], whether in the clinic or the OR, increases the detection of tumors," writes Jeffrey M. Holzbeierlein, MD.
This article presents an overview of the pathophysiology of varicoceles and discusses indications for treatment, two primary repair techniques, and treatment outcomes.
"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
A 21-year-old male presented to the emergency department for evaluation of testicular pain and swelling 5 days after being struck in the groin.
"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.
"The ABU is committed to evolving a [life-long learning] program that diplomates find relevant and less burdensome. We will always welcome diplomates’ feedback regarding this evolving program," writes H. Ballentine Carter, MD.
"A global consensus on standardization of terminology, separation of LUTS vs pain for outcome, HL positivity and negativity, markers for disease, and the role of new interventions for local vs systemic therapy is needed," writes Gopal H. Badlani, MD.
"No matter the most accurate interpretation of the current spate of retirements, the volume of vacancies promises to alter the political calculus in Washington," writes the AACU's Brian Henderson.
Closing out his discussion on prostate cancer, Michael S. Leapman, MD, MHS, highlights practical advice and shares hope for future improvements in the treatment landscape.
These videos depict key steps of office-based approaches to hydrocelectomy and vasectomy reversal.
A 61-year-old female complains of acute-onset right-sided flank and abdominal pain. She describes associated nausea, but denied urinary symptoms, hematuria, fever, or chills.
"The expert testified that the standard of care after penile prosthesis surgery is to leave the implant in a semi-inflated state for 4 to 6 weeks, when in fact the standard is to keep the implant in a deflated state," writes Brianne Goodwin, JD, RN.
A 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.
"This article describes the surgical steps in this new technique and our promising preliminary results," writes Reynaldo Gomez, MD.
Urology Times SUO internship program member Brandon Manley, MD, reports on an SUO presentation highlighting several interesting findings on advanced prostate cancer with variant histology.
In the arena of focal therapy for prostate cancer, standardization of management will be a key component of quality data going forward, says Scott Eggener, MD.
Peter C. Black, MD, discusses the current state of immune checkpoint inhibition for bladder cancer in this article from Urology Times SUO internship program member William Parker, MD.
A recent human study sought to replicate previous success seen in animal models of reperfusion injury, reports Urology Times SUO internship program member Katie Murray, DO.
"As a urologic community, we should promote the use of AS for favorable-risk disease to reduce the downstream harms of screening while preserving the benefits of early detection for life-threatening cases," writes Stacy Loeb, MD, MSc.
In this video, Nicholas R. Rocco, MD, Michael G. Santomauro, MD, and colleagues, illustrate a safe and effective way to treat a large-volume prostate causing obstructive lower urinary tract symptoms.